What 4 Analyst Ratings Have To Say About Zimmer Biomet Holdings
Analysts have provided the following ratings for Zimmer Biomet Holdings (NYSE:ZBH) within the last quarter:
Morgan Stanley Maintains Equal-Weight on Zimmer Biomet Holdings, Lowers Price Target to $115
Morgan Stanley analyst Cecilia Furlong maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight and lowers the price target from $132 to $115.
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's session, 326 stocks hit new 52-week lows.